Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Cell-Targeting Nanomedicine for Bladder Cancer: A Cellular Bioengineering Approach for Precise Drug Delivery Publisher



Hoseini ZS1 ; Zeinalilathori S2 ; Fathikarkan S3, 4 ; Zeinali S5 ; Rahdar A6 ; Siddiqui B7 ; Kharaba Z8 ; Pandey S9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Chemistry and Biochemistry, University of Delaware, United States
  3. 3. Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, 94531-55166, Iran
  4. 4. Department of Advanced Sciences and Technologies in Medicine, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, 9414974877, Iran
  5. 5. Harper & Keele Veterinary School, Keele University, Staffordshire, United Kingdom
  6. 6. Department of Physics, Faculty of Sciences, University of Zabol, Zabol, 538-98615, Iran
  7. 7. Department of Pharmacy, Faculty of Biological Sciences, Quaid-I-Azam University, Islamabad, Pakistan
  8. 8. Department of Pharmacy Practice and Pharmacotherapeutics, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
  9. 9. School of Bioengineering and Food Technology, Faculty of Applied Sciences and Biotechnology, Shoolini University, Himachal Pradesh, Solan, 173229, India

Source: Journal of Drug Delivery Science and Technology Published:2024


Abstract

Bladder cancer poses considerable therapeutic difficulties owing to its elevated rates of recurrence and the constraints of existing treatment methods. This study examines the possibility of cell-targeting nanomedicine as a viable strategy to improve the accuracy of bladder cancer treatment. The article explores the use of carbon-based nanostructures, metallic nanoparticles, and new methods in designing tailored drug delivery systems, drawing on knowledge from cellular bioengineering. This study focuses on the interaction between nanoparticles and the urothelium, with a specific emphasis on the potential of silver nanoparticles (AgNPs) in treating non-muscle invasive bladder cancer (NMIBC). The study highlights how AgNPs may induce apoptosis and stop the cell cycle, offering promising prospects for NMIBC therapy. Furthermore, the use of carbon nanotubes (CNTs) in precise and targeted treatment using photo-thermal ablation is examined. This study highlights the revolutionary capabilities of nanotechnologies, indicating a fundamental change towards improved and individualized therapies for bladder cancer. Therefore, this paper is an essential reference for researchers, physicians, and academics who are committed to progressing cancer therapies. © 2024 Elsevier B.V.
Related Docs
1. Gene Therapy As an Emerging Therapeutic Approach to Breast Cancer: New Developments and Challenges, Human Gene Therapy (2021)
2. Gene Therapy and Genetic Vaccines, Cancer Immunology: Bench to Bedside Immunotherapy of Cancers# Second Edition (2020)
3. Cancer-Associated Fibroblasts (Cafs) and Tumor-Associated Macrophages (Tams); Where Do They Stand in Tumorigenesis and How They Can Change the Face of Cancer Therapy?, European Journal of Pharmacology (2022)
4. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (1)
Alimohammad Alizadeh (1)